First Generic Of B+L’s OTC Switch Lumify Approved For Dr. Reddy’s Amid Patent Infringement Battle

Bausch + Lomb, Corporation received approval to extend its Lumify eye drop line with a preservative-free formulation a month after the first generic of the brimonidine tartrate OTC switch was approved as B+L litigates to protect its patents for the product.

The Canadian firm, which announces its latest results on 1 May, received approval from the Food and Drug Administration in a 19 April letter for its new drug application submitted in May 2023 for Lumify Preservative Free (brimonidine tartrate 0.025% ophthalmic solution). The agency’s Center for Drug Evaluation and Research notes in the